A. Eden Evins

12.6k total citations · 2 hit papers
186 papers, 8.6k citations indexed

About

A. Eden Evins is a scholar working on Physiology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, A. Eden Evins has authored 186 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Physiology, 54 papers in Pharmacology and 45 papers in Psychiatry and Mental health. Recurrent topics in A. Eden Evins's work include Smoking Behavior and Cessation (66 papers), Cannabis and Cannabinoid Research (39 papers) and Nicotinic Acetylcholine Receptors Study (36 papers). A. Eden Evins is often cited by papers focused on Smoking Behavior and Cessation (66 papers), Cannabis and Cannabinoid Research (39 papers) and Nicotinic Acetylcholine Receptors Study (36 papers). A. Eden Evins collaborates with scholars based in United States, United Kingdom and South Korea. A. Eden Evins's co-authors include Donald Goff, Corinne Cather, David C. Henderson, Oliver Freudenreich, David Schoenfeld, Melissa A. Culhane, Maurizio Fava, Gladys N. Pachas, Diego A. Pizzagalli and Paul M. Copeland and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

A. Eden Evins

178 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial

2016 632 citations Robert M. Anthenelli, Thomas McRae et al. profile →
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review

2016 578 citations A. Eden Evins et al. profile →

Peers

Countries citing papers authored by A. Eden Evins

Since Specialization

Citations

This map shows the geographic impact of A. Eden Evins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Eden Evins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Eden Evins more than expected).

Fields of papers citing papers by A. Eden Evins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Eden Evins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Eden Evins. The network helps show where A. Eden Evins may publish in the future.

Co-authorship network of co-authors of A. Eden Evins

This figure shows the co-authorship network connecting the top 25 collaborators of A. Eden Evins. A scholar is included among the top collaborators of A. Eden Evins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Eden Evins. A. Eden Evins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characteristics of Adolescents Presenting for a Pharmacotherapy Vaping Cessation Trial who Never Smoked Tobacco Regularly 2025 ·Drug and Alcohol Dependence ·(unknown), (unknown), Gladys N. Pachas, (unknown), Jason Dufour, (unknown), (unknown), Kevin Potter, (unknown), A. Eden Evins	1
2	US state implementation of policies restricting sales of flavoured E-cigarettes: a qualitative analysis 2025 ·Tobacco Control ·Gina Kruse, G. B. Chadwick, (unknown), (unknown), Víctor Méndez Muñoz, (unknown), (unknown), Ho Van Chien, (unknown), A. Eden Evins, Nancy A. Rigotti, Douglas E. Levy	0
3	Racial Differences in Nicotine Reduction: Pooled Results from Two Double-Blind Randomized Controlled Trials 2024 ·Journal of Racial and Ethnic Health Disparities ·(unknown), Nicolle M. Krebs, Junjia Zhu, Kimberly Horn, Jonathan Foulds, A. Eden Evins, Joshua Muscat	2
4	Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity 2024 ·Neuropsychopharmacology ·(unknown), (unknown), (unknown), Kevin Potter, Gladys N. Pachas, A. Eden Evins, Jodi M. Gilman	2
5	Do tobacco regulatory and economic factors influence smoking cessation outcomes? A post-hoc analysis of the multinational EAGLES randomised controlled trial 2024 ·BMJ Open ·(unknown), (unknown), Benjamin S. McKenna, Phillip Saccone, Thomas McRae, A. Eden Evins, Robert M. Anthenelli	1
6	Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership 2023 ·Frontiers in Psychiatry ·Megan Cooke, Kevin Potter, (unknown), (unknown), Randi M. Schuster, Brenden Tervo‐Clemmens, Bettina B. Hoeppner, Gladys N. Pachas, A. Eden Evins, Jodi M. Gilman	10
7	Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns 2022 ·Drug and Alcohol Dependence ·Brenden Tervo‐Clemmens, William A. Schmitt, (unknown), Megan Cooke, Randi M. Schuster, (unknown), Gladys N. Pachas, A. Eden Evins, Jodi M. Gilman	12
8	Implementing Chronic Care Model Treatments for Cigarette Dependence in Community Mental Health Clinics 2022 ·Journal of Dual Diagnosis ·Sandra J. Japuntich, (unknown), (unknown), Sara J. Becker, Sarah A. Helseth, Steven S. Fu, Jennifer W. Tidey, A. Eden Evins, Rebekah Pratt	2
9	Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain 2022 ·BMJ Open ·(unknown), Minhae Kim, (unknown), Nathaniel D. Mercaldo, Robert R. Edwards, Vitaly Napadow, Yi Zhang, (unknown), Zeynab Alshelh, A. Eden Evins, Marco L. Loggia, Jodi M. Gilman	3
10	State-Level Recreational Cannabis Legalization Is Not Differentially Associated with Cannabis Risk Perception Among Children: A Multilevel Regression Analysis 2022 ·Cannabis and Cannabinoid Research ·Jodi M. Gilman, (unknown), (unknown), (unknown), (unknown), Kevin Potter, Brenden Tervo‐Clemmens, Joshua L. Roffman, A. Eden Evins	0
11	Polygenic score for cigarette smoking is associated with ever electronic‐cigarette use in a college‐aged sample 2021 ·Addiction ·Megan Cooke, (unknown), K. Elizabeth, Jodi M. Gilman, Hermine H. Maes, Roseann E. Peterson, Elizabeth Prom‐Wormley, A. Eden Evins, Randi M. Schuster, (unknown)	3
12	Integrated Smoking Cessation for Smokers With Serious Mental Illness: Protocol for a Convergent Mixed Methods Implementation Evaluation Study 2021 ·JMIR Research Protocols ·(unknown), (unknown), (unknown), (unknown), Gladys N. Pachas, A. Eden Evins, Michael D. Fetters	1
13	Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active‐ and placebo‐controlled EAGLES trial 2019 ·Depression and Anxiety ·Catherine R. Ayers, Jaimee L. Heffner, Cristina Russ, David Lawrence, Thomas McRae, A. Eden Evins, Robert M. Anthenelli	13
14	Treatment of Tobacco Use Disorders in Smokers with Serious Mental Illness 2015 ·Harvard Review of Psychiatry ·A. Eden Evins, Corinne Cather, (unknown)	69
15	Detecting treatment‐covariate interactions using permutation methods 2015 ·Statistics in Medicine ·Rui Wang, David Schoenfeld, Bettina B. Hoeppner, A. Eden Evins	6
16	Systematic review and meta-analysis of opioid antagonists for smoking cessation 2014 ·BMJ Open ·Sean P. David, Isabella Chu, Tim Lancaster, Lindsay F Stead, A. Eden Evins, Judith J. Prochaska	23
17	Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders 2011 ·The Journal of Clinical Psychiatry ·Nadia Iovieno, Enrico Tedeschini, Kate H. Bentley, A. Eden Evins, George I. Papakostas	56
18	A double‐blind, placebo‐controlled trial of adjunctive donepezil in treatment‐resistant mania 2006 ·Bipolar Disorders ·A. Eden Evins, Christina M. Demopulos, Andrew A. Nierenberg, Melissa A. Culhane, Lori Eisner, Gary Sachs	30
19	Inositol augmentation of lithium or valproate for bipolar depression 2006 ·Bipolar Disorders ·A. Eden Evins, Christina M. Demopulos, Iftah Yovel, Melissa A. Culhane, (unknown), Louisa D. Grandin, Andrew A. Nierenberg, (unknown)	54
20	A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia 2001 ·Nicotine & Tobacco Research ·A. Eden Evins, (unknown), Nancy A. Rigotti, (unknown), Corinne Cather, Donald Goff	157

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact